期刊文献+

肝细胞癌组织中miR-218的表达及其临床意义 被引量:1

Expression of miR-218 in Hepatocellular Carcinoma and Its Clinical Significance
下载PDF
导出
摘要 【目的】研究miR-218在肝细胞癌(Hepatocellularcarcinoma,HCC)组织中的表达并探讨其临床意义。【方法】收集HCC手术组织标本54例,30例癌旁正常组织作为对照,采用实时荧光定量PCR(qRT-PCR)检测HCC组织及对照组织中miR-218的表达情况,分析miR_218表达水平与HCC临床病理参数之间的关系。【结果】与癌旁对照组织相比,miR-218在HCC组织表达普遍下调,差异具有统计学意义(P〈0.01),癌旁对照组织中miR-218平均表达量约为HCC的2.90倍;miR-218下调表达程度与HCC恶性程度、肿瘤分化程度、肝内和肝外转移及门静脉癌栓有关,miR_218的表达水平与HCC患者年龄、性别、饮酒史、HBsAg、肿瘤大小、是否合并肝硬化等无关。【结论]miR-218与HCC的发生、临床进展密切相关,其可能成为HCC新的潜在的治疗靶点及诊断和预后的分子标志物。 [Objective] To investigate the expression of miR-218 in hepatocellular carcinoma(HCC)and its clinical significance. [Methods] Totally 54 cases of HCC biopsies were collected. And 30 normal peri-carcino- ma tissues were selected as the control. Real-time fluorescent qtlantitive PCR(qRT-PCR) was used to detect the expression of miR-218 in HCC and control tissues. The relationship between miR-218 expression and HCC clinicopathological parameters was analyzed. [Results] Compared with the control tissues, the expression of miR-218 in HCC tissue was consistently down-regulated, and there was significant difference( P d0.01). The average expression level of miR-218 in control tissues was 2.90-fold of HCC tissue. The expression level of miR-218 was related with HCC malignancy, tumor differentiation, intrahepatic and extrahepatic metastasis and portal vein embolus. There was no correlation between miR-338 expression and the age, sex, alcohol history, HBsAg, tumor size and the combination with liver cirrhosis of HCC patients. [Conclusion] MiR-218 is closely associated with the carcinogenesis and clinical progression of HCC. MiR-218 may be a new potential therapy target and molecule marker of the diagnosis and prognosis of HCC.
出处 《医学临床研究》 CAS 2013年第4期751-753,共3页 Journal of Clinical Research
关键词 肝细胞 病理学 Carcinoma, Hepatocellular/PA
  • 相关文献

参考文献14

  • 1He L,Hannon GJ. MicroRNAs: small RNAs with a big rolein gene regulation[J]. Nat Rev Genet,2004,5(7): 522-531.
  • 2周建大,谭建湘,谢慧清,汪阳,李文波,钟石.原发性皮肤黑色素瘤的microRNA基因芯片研究[J].中国医师杂志,2010,12(3):405-406. 被引量:9
  • 3吕辉,唐云云,唐海林,张志伟,周秀田,罗招阳.miR-124在胃癌中的表达及其临床意义[J].医学临床研究,2012,29(3):388-390. 被引量:11
  • 4Wei CL, Wu Q, Vega VB, et al . A global map of p53 tran-scription-factor binding sites in the human genome[J]. Cell,2006, 124(1):207-219.
  • 5Lin He,Xingyue He,Lee V-, et al . A microRNA componentof the p53 tumour suppressor network [ J]. Nature , 2007,447(7148):1130-1135.
  • 6David C* Andrea Flesken-Nikitin, Andrew K, et al . MicroR-NA-34b and microRNA-34c are targets of p53 and cooperatein control of cell proliferation and adhesion-independentgrowth[J]. Cancer Res ,2007 , 67( 18):8433-8438.
  • 7Chang TC,Wentzel EA,Kent OA,et al . Transactivation ofmiR-34a by p53 broadly influences gene expression and pro-motes apoptosis[J]. Mol Cell ,2007, 26(5):745-752.
  • 8Welch C,Chen Y,Stallings RL. MicroRNA-34a functions asa potential tumor suppressor by inducing apoptosis in neuro-blastoma cells[J]. Oncogene ,2007 , 26(34) : 5017-5022.
  • 9Davidson MR,Larsen JE, Yang IA, et al . MicroRNA-218 isdeleted and downregulated in lung squamous cell carcinoma[J]. PLoS One ,2010,5(9) :el2560.
  • 10rtinez I,Gardiner AS, Board KF, et al . Human papillo-mavirus type 16 reduces the expression of microRNA-218 incervical carcinoma cells[J]. Oncogene , 2008, 27(18): 2575-2582.

二级参考文献9

共引文献1825

同被引文献14

  • 1陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
  • 2Tang H ,Liu X ,Wang Z ,et al. Interaction of hsa-miR-381 and glioma suppressor LRRC4 is involved in glioma growth[J]. Brain Res,2011,1390(1):21-32.
  • 3Wu J,Wu G,Lv L,et al. MicroRNA-34a inhibits migration and inva- sion of colon cancer cells via targeting to Fra-1 [J]. Carcinogenesis, 2012,33 (3) :519-28.
  • 4Liu C ,Kelnar K, Liu B ,et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44[J]. Nat Med ,2011,17(2) :211-215.
  • 5Yang P,Li QJ,Feng Y,et al. TGF-I3-miR-34a-CCL22 signaling-in- duced Treg cell recruitment promotes venous metastases of HBV- positive hepatocellular carcinoma[J]. Cancer Ce11,2012,22(3):291- 303.
  • 6Iliopoulos D,Lindahl-Allen M ,Polytarchou C,et al. Loss of miR-200 inhibition of Suzl2 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells[J]. Mol Cell, 2010,39(5 ) :761-772.
  • 7Shimono Y,Zabala M,Cho RW,et al. Downregulation of miRNA- 200c links breast cancer stem ceils with normal stem cells[J]. Cell, 2009,138 (3) :592-603.
  • 8[ Howe EN,Cochrane DR,Richer JK. Targets of miR-200c mediate suppression of cell motility and anoikis resistance[J]. Breast Cancer Res, 2011,13(2) :R45.
  • 9Tang H,Bian Y,Tu C ,et al. The miR-183/96/182 cluster centralizes to regulate oxidative apoptosis and sensitizes cells to chemotherapy in gliomas[J]. Current Cancer Drug Targets. 2013,13(2) :221-231.
  • 10Ma L,Teruya-Feldstein J,Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer[J]. Nature, 2007,449 ( 7163 ) : 682-688.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部